SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

1st Quarter Results

2 May 2014 07:00

RNS Number : 1326G
Rentokil Initial PLC
02 May 2014
Β 

ο»Ώ

Β 

RENTOKIL INITIAL PLC (RTO)

INTERIM MANAGEMENT STATEMENT

2 May 2014

Β 

Β (Β£m)

Q1 2014

Growth

AER

AER

CER

Revenue

412.3

(5.7%)

(0.6%)

Adjusted operating profit1

38.8

(1.0%)

7.6%

Adjusted profit before tax2

25.1

(7.0%)

5.7%

Profit before tax

19.3

6.0%

21.7%

Β 

Revenue (at CER)

Β 

On an organic basis revenue increased by 0.4%, driven by good growth in our Emerging (+8.8%) and Growth (+2.2%) quadrants. Revenue performance was held back by lower revenues in the Protect & Enhance quadrant (-1.7%) and, as expected, Benelux in particular. Acquisitions, primarily in our Emerging and Growth quadrants, contributed 1% to revenue, while disposals in our Manage for Value quadrant of our Belgian flat linen business and Korean JV in 2013 reduced revenue by 2%, to give total revenue for the period down 0.6%.

Β 

Profit (at CER)

Β 

Adjusted operating profit increased by 7.6%, reflecting growth in France, Germany, North America and Asia as well as lower central and regional overheads, partly offset by lower profits in the Benelux.

Β 

Adjusted profit before tax at actual exchange rates has been negatively impacted by Β£2.4m due to the strengthening of Sterling. Based on current exchange rates the impact of currency movements would be around Β£14m for the full year (Β£1m less than the Β£15m referred to at the time of the preliminary results).

Β 

Restructuring and one-off costs for continuing operations were significantly lower in Q1 at Β£2.1m versus Β£5.1m last year contributing to the increase in profit before tax of 21.7%. We now expect restructuring and one-off costs to be in the region of Β£10m for the year (c. Β£10m lower than indicated at the preliminary results).

Β 

Cash

Β 

Cash flow in the quarter was in line with expectations, with the group on track to generate a significant improvement in free cash flow in the year through lower restructuring costs, as well as reduced capex and lower working capital outflows and pension contributions. The proceeds from the sale of Initial Facilities, amounting to Β£250m, were received on 18 March.

Β 

M&A

Β 

We continue to expand our global footprint in pest control, acquiring 10 businesses in Q1 with a combined expected revenue impact this year of Β£22.4m. These include the acquisition of a leading Chilean pest business as well as four small transactions in North America. The group also acquired small pest control businesses in Ireland, Italy and Spain.

Β 

Β 

Commenting on the Q1 results Andy Ransom, CEO of Rentokil Initial plc, said:

Β 

"I am pleased to report that revenue, profit and cash performance in the first quarter has been in line with our expectations. Good organic revenue growth was achieved in our Emerging and Growth quadrants while, as expected, challenging trading conditions persisted in our Protect & Enhance markets, Benelux in particular.

Β 

"As indicated in our strategy presentation in February our immediate focus is improved profitability and cash generation. Profit growth in the quarter reflects the benefit of more effective businesses and reducing overheads, as well as lower restructuring and one-off costs, and we are on track to deliver a significant increase in free cash flow in 2014. We remain confident in making further progress in the remainder of the year."

Β 

Β 

Β 

All figures exclude Initial Facilities which was sold on 18 March 2014 and City Link which was sold on 29 April 2013

AER - actual exchange rates; CER - constant 2013 exchange rates

1 before amortisation and impairment of intangibles (excluding computer software), reorganisation costs and one-off items

2 before amortisation and impairment of intangibles (excluding computer software), reorganisation costs/one-off items and net interest credit from pensions

Β 

Β 

Β 

Β 

Β 

Β 

Enquiries:

Investors / Analysts enquiries:

Katharine Rycroft, Head of Investor Relations Rentokil Initial plc 07811 270734

Β 

Media enquiries:

Malcolm Padley, Corporate Communications Rentokil Initial plc 07788 978 199

Justine McIlroy, Oliver Hughes Brunswick Group 020 7404 5959

Β 

Β 

Conference Call Β 

Β 

A conference call for investors and analysts will be held at 9.15am (UK time) today to discuss this statement.

Β 

Participant Details

London, UK

+44 (0) 20 3427 1912

Paris, France

+33 (0)1 76 77 22 23

Hong Kong

+852 3009 5112

New York, USA

+1 646 254 3367

Participant PIN Code

9083880#

Β 

Playback Details

London, UK

+44 (0) 20 3427 0598

Paris, France

+33 (0)1 74 20 28 00

Hong Kong

+852 3011 4669

New York, USA

+1 347 366 9565

Playback Pin Code

9083880#

Β 

Notes:

The Company groups its categories and geographies into a growth potential and profit contribution matrix. Allocation to each quadrant will drive implementation and execution of the right strategy for each business and facilitates efficient allocation of capital to where it is most needed and where it will generate the best returns:

Β 

Emerging:

Β· Geographies include: Asia, the Middle East, North Africa, Turkey, East Africa and Latin America

Β 

Manage for Value:

Β· Geographies include: Ireland, Spain, Portugal, Italy and Greece

Β 

Growth:

Β· Geographies include: North America, UK, Germany, Austria, Switzerland and the Caribbean

Β 

Protect & Enhance:

Β· Geographies include: France, Benelux, Nordics, Australia, New Zealand and South Africa

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSEAXSFELALEFF
Date   Source Headline
21st May 20267:00 amRNSAppointment of CEO, North America
8th May 202610:30 amRNSHolding(s) in Company
7th May 20264:40 pmRNSResult of AGM
23rd Apr 20264:25 pmRNSFinal Dividend – Pence Sterling Amount Payable
23rd Apr 20262:30 pmRNSIssuance of $500 million 4.625% Notes due 2031
21st Apr 202610:30 amRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ1 Trading Update
15th Apr 20267:00 amRNSDirectorate Change
30th Mar 202610:30 amRNSHolding(s) in Company
26th Mar 20263:46 pmRNSDirector/PDMR Shareholding
25th Mar 202610:50 amRNSAnnual Financial Report
17th Mar 20264:30 pmRNSDirector/PDMR Shareholding
16th Mar 202610:32 amRNSHolding(s) in Company
16th Mar 202610:32 amRNSHolding(s) in Company
12th Mar 202610:30 amRNSHolding(s) in Company
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
9th Mar 202611:15 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSPreliminary Results
5th Mar 20267:00 amRNSChair Succession Planning Update
23rd Feb 202610:30 amRNSHolding(s) in Company
19th Feb 20262:50 pmRNSDirector Declaration
12th Feb 20265:30 pmRNSNotice of Early Redemption
20th Jan 202610:25 amRNSHolding(s) in Company
19th Jan 202610:30 amRNSHolding(s) in Company
16th Jan 20263:00 pmRNSHolding(s) in Company
14th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 20267:00 amRNSDirectorate change
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
5th Dec 202510:30 amRNSHolding(s) in Company
5th Dec 202510:30 amRNSHolding(s) in Company
26th Nov 20254:25 pmRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
27th Oct 202510:30 amRNSHolding(s) in Company
23rd Oct 202511:45 amRNSHolding(s) in Company
23rd Oct 20257:00 amRNSQ3 Trading Update
21st Oct 202510:00 amRNSHolding(s) in Company
14th Oct 202510:00 amRNSHolding(s) in Company
1st Oct 202510:30 amRNSBlock listing Interim Review
30th Sep 202510:30 amRNSCompletion of France Workwear business sale
25th Sep 20254:15 pmRNSDirector/PDMR Shareholding
24th Sep 20256:00 pmRNSDirector Declaration
26th Aug 202512:30 pmRNSInterim Dividend – Pence Sterling Amount Payable
7th Aug 202511:10 amRNSHolding(s) in Company
31st Jul 20257:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.